George P. Denny III - 29 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role: Member of 10% owner group
Signature: /s/ George P. Denny III
Issuer symbol: CMRA on OTC
Transactions as of: 29 Dec 2023
Net transactions value: +$107,622
Form type: 4
Filing time: 11 Jan 2024, 19:14:17 UTC
Previous filing: 11 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	12.0% Senior Secured Convertible Notes	Purchase	$107,622				$107,622	29 Dec 2023	Common Stock	1,956,763	$0.0550	By Denny Family Partners II, LLC	F1, F2
transaction	CMRA	Warrants to Purchase Common Stock	Purchase	$0	+3,913,526		$0.000000	3,913,526	29 Dec 2023	Common Stock	3,913,526	$0.0550	By Denny Family Partners II, LLC	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Denny Family Partners II, LLC ("DFP") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
F2	The reporting person disclaims beneficial ownership of the securities held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein.

Content

Denny Family Partners II, LLC ("DFP") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.

The reporting person disclaims beneficial ownership of the securities held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein.